No abstract available
Publication types
-
Letter
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
MeSH terms
-
Aged
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Antibodies, Monoclonal / therapeutic use*
-
Berylliosis / drug therapy*
-
Berylliosis / immunology
-
Chronic Disease
-
Double-Blind Method
-
Female
-
Humans
-
Immunity, Cellular / drug effects
-
Infliximab
-
Male
-
Middle Aged
-
Quality of Life
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antibodies, Monoclonal
-
Infliximab
Associated data
-
ClinicalTrials.gov/NCT00111917